Investors Contact Payment Careers Research Request
Interpace Biosciences, Inc.
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
  • Diagnostics
  • Pharma Solutions
    • Overview
    • Biomarkers Solutions
    • Genomics Services/
      Molecular Dx
    • Anatomic Path, Flow, and Cytogenetics
    • Integrated Biorepository
    • Bioinformatics Solutions
    • SpatialPlex™ Services
  • Support
  • Labs
  • News & Media
    • Press Releases
    • In The News
    • Presentations
    • Events
  • Investors
  • Contact
  • Payment
  • Careers
  • Research Request

Press Releases

News & Media

News & Media

  • Press Releases
  • In The News
  • Presentations
  • Events

Interpace Diagnostics Receives Medicare Coverage For Its ThyraMIR™ Micro RNA Gene Expression Classifer

Feb 17, 2016

PancraGen® Clinical Utility Study Published in Diagnostic Pathology

Jan 28, 2016

Interpace Diagnostics Announces New Medicare Local Coverage Determination for Molecular Testing of Pancreatic Cysts

Jan 20, 2016

Interpace Diagnostics' New Molecular Test for Thyroid Nodules Now Available Through LabCorp

Jan 12, 2016

Interpace Diagnostics Group Begins Trading on NASDAQ

Dec 23, 2015
    • 1...
    • 13
    • 14
    • 15
    • 16
    • 17
    • 18
    • 19
    • 20
    • 21
    • 22
    © 2022 Interpace Biosciences, Inc. All Rights Reserved.
    Privacy Policy HIPAA Privacy Disclaimer Sitemap
    We Own Our Future Logo
    • Linkedin